These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2896067)

  • 1. [In vitro secretion of somatostatin (SRIH) by human adenomatous somatotropic cells. Relation with somatotropic hormone (GH) release and modulation by thyroliberin (TRH)].
    Peillon F; Liappi G; Garnier P; Brandi AM; Evain-Brion D; Dodeur M; Gautron JP; Donnadieu M; Michard M; Racadot J
    C R Acad Sci III; 1988; 306(4):161-6. PubMed ID: 2896067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normal and growth hormone (GH)-secreting adenomatous human pituitaries release somatostatin and GH-releasing hormone.
    Joubert D; Benlot C; Lagoguey A; Garnier P; Brandi AM; Gautron JP; Legrand JC; Peillon F
    J Clin Endocrinol Metab; 1989 Mar; 68(3):572-7. PubMed ID: 2493037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normal and adenomatous human pituitaries secrete thyrotropin-releasing hormone in vitro: modulation by dopamine, haloperidol, and somatostatin.
    Le Dafniet M; Lefebvre P; Barret A; Mechain C; Feinstein MC; Brandi AM; Peillon F
    J Clin Endocrinol Metab; 1990 Aug; 71(2):480-6. PubMed ID: 1974264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neurohormones coming from the normal and tumoral human anterior pituitary. Secretion and regulation in vitro].
    Peillon F; Le Dafniet M; Garnier P; Feinstein MC; Donnadieu M; Barret A; Gautron JP; Brandi AM; Benlot C; Lagoguey A
    Pathol Biol (Paris); 1989 Sep; 37(7):840-5. PubMed ID: 2576565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone (GH)-releasing hormone tonically inhibits in vitro endogenous somatostatin in human GH-secreting tumors.
    Mouhieddine OE; Levy L; Benlot C; Peillon F; Joubert D
    J Clin Endocrinol Metab; 1995 May; 80(5):1691-5. PubMed ID: 7745020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptors and neurohormones in human pituitary adenomas.
    Peillon F; Le Dafniet M; Garnier P; Brandi AM; Moyse E; Birman P; Blumberg-Tick J; Grouselle D; Joubert-Bression D
    Horm Res; 1989; 31(1-2):13-8. PubMed ID: 2566572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between somatostatin and TRH on growth hormone secretion in perifused human growth hormone tumor cells.
    Le Dafniet M; Garnier P; Brandi AM; Bression D; Scherrer H; Racadot J; Peillon F
    Horm Res; 1985; 21(4):235-9. PubMed ID: 2861154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatostatin receptors in human growth hormone and prolactin-secreting pituitary adenomas.
    Moyse E; Le Dafniet M; Epelbaum J; Pagesy P; Peillon F; Kordon C; Enjalbert A
    J Clin Endocrinol Metab; 1985 Jul; 61(1):98-103. PubMed ID: 2860120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phorbol ester and phospholipase C-induced growth hormone secretion from pituitary somatotroph adenoma cells in culture: effects of somatostatin, bromocriptine, and pertussis toxin.
    Ikuyama S; Nawata H; Kato K; Natori S; Ibayashi H
    J Clin Endocrinol Metab; 1987 Mar; 64(3):572-7. PubMed ID: 2880863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone (GH)-releasing peptide stimulation of GH release from human somatotroph adenoma cells: interaction with GH-releasing hormone, thyrotropin-releasing hormone, and octreotide.
    Renner U; Brockmeier S; Strasburger CJ; Lange M; Schopohl J; Müller OA; von Werder K; Stalla GK
    J Clin Endocrinol Metab; 1994 May; 78(5):1090-6. PubMed ID: 8175966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture.
    Ishibashi M; Yamaji T
    J Clin Endocrinol Metab; 1985 May; 60(5):985-93. PubMed ID: 2858494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential inhibition of growth hormone secretion by analogs selective for somatostatin receptor subtypes 2 and 5 in human growth-hormone-secreting adenoma cells in vitro.
    Tulipano G; Bonfanti C; Milani G; Billeci B; Bollati A; Cozzi R; Maira G; Murphy WA; Poiesi C; Turazzi S; Giustina A
    Neuroendocrinology; 2001 May; 73(5):344-51. PubMed ID: 11399907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Regulation of hormone secretion in primary cell cultures of human somatotropinomas].
    Bulatov AA; Komolov IS; Smirnova NB; Trunin IuK; Serpukhovitin SIu; Dzeranova LK; Marova EI; Dedov II
    Biull Eksp Biol Med; 1992 Apr; 113(4):406-9. PubMed ID: 1356509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M; Yamaji T
    J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of growth hormone secretion from porcine fetal and neonatal pituitary tissue in vitro by growth hormone-releasing hormone, somatostatin, and insulin-like growth factor.
    Torronteras R; Gracia-Navarro F; Elsaesser F
    Neuroendocrinology; 1997 Feb; 65(2):117-28. PubMed ID: 9067989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of somatostatin receptors controlling growth hormone and thyrotropin secretion in the chicken using receptor subtype-specific agonists.
    Geris KL; de Groef B; Rohrer SP; Geelissen S; Kühn ER; Darras VM
    J Endocrinol; 2003 May; 177(2):279-86. PubMed ID: 12740016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatostatin receptors, adenylate cyclase activity, and growth hormone (GH) response to octreotide in GH-secreting adenomas.
    Bertherat J; Chanson P; Dewailly D; Dupuy M; Jaquet P; Peillon F; Epelbaum J
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1577-83. PubMed ID: 7903312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin receptors on thyrotropin-secreting pituitary adenomas: comparison with the inhibitory effects of octreotide upon in vivo and in vitro hormonal secretions.
    Bertherat J; Brue T; Enjalbert A; Gunz G; Rasolonjanahary R; Warnet A; Jaquet P; Epelbaum J
    J Clin Endocrinol Metab; 1992 Aug; 75(2):540-6. PubMed ID: 1353505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlative studies between the presence of thyrotropin-releasing hormone (TRH) receptors and the in vitro stimulation of growth-hormone (GH) secretion in human GH-secreting adenomas.
    Le Dafniet M; Garnier P; Bression D; Brandi AM; Racadot J; Peillon F
    Horm Metab Res; 1985 Sep; 17(9):476-9. PubMed ID: 2864309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Release of thyrotropin releasing hormone (TRH) from human prolactin-secreting pituitary adenoma cells. Modulation by dopamine].
    Le Dafniet M; Blumberg-Tick J; Yuan Li J; Brandi AM; Bression D; Barret A; Feinstein MC; Peillon F
    C R Acad Sci III; 1988; 306(3):129-34. PubMed ID: 3126991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.